Skip to main content
. 2014 Jun 15;7(7):3975–3983.

Figure 3.

Figure 3

Survival analysis of cyclin D1 expression in second primary malignancies. Survival time (months) relative to the expression score of cyclin D1 (high versus low). Patients with high cyclin D1 expression exhibited decreased overall survival time compared those with low cyclin D1 expression. P = 0.040, log-rank test.